Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin’s lymphoma

被引:0
|
作者
Natasa Colovic
Vladimir Jurisic
Tatjana Terzic
Henry Dushan Atkinson
Milica Colovic
机构
[1] Institute of Hematology Clinical Center Serbia,Imperial College School of Medicine
[2] Institute for Pathology,undefined
[3] St Mary’s Hospital,undefined
来源
Archives of Dermatological Research | 2009年 / 301卷
关键词
Cutaneous B-cell non-Hodgkin’s lymphoma; Scalp; High grade; Follicle center lymphoma; Immunohistochemistry; Immunochemotherapy; Rituximab;
D O I
暂无
中图分类号
学科分类号
摘要
The case of a 44-year-old man with a primary cutaneous large B-cell non-Hodgkin’s lymphoma of the scalp is reported. His mother died of gastric lymphoma and his sib brother is in a 20-year remission of T-cell lymphoma. The patient presented with a 16-year history of occipital and parietal alopecia and a recently worsening scalp rash. The histopathology and immunohistochemistry performed in April 2006 indicated a bcl-6+, MUM− and bcl-2−, primary cutaneous follicle center B-cell non-Hodgkin’s lymphoma, with an aggressive transformation to a diffuse large B-cell lymphoma. Bone marrow biopsy and CT chest, abdomen, and pelvis were negative for systemic lymphoma. The patient had an excellent clinical and histological resolution following 8 cycles of rituximab and CHOP protocol immunochemotherapy, and remains in complete remission until now. The protracted indolent phase of the disease, the familial history of lymphoma, the histological aggressive features and the patient’s excellent response to immunochemotherapy all contribute to a very unusual manifestation of this disease.
引用
收藏
页码:689 / 692
页数:3
相关论文
共 50 条
  • [21] Rituximab in B-cell disorders other than non-Hodgkin's lymphoma
    Bosly, A
    Keating, MJ
    Stasi, R
    Bradstock, K
    ANTI-CANCER DRUGS, 2002, 13 : S25 - S33
  • [22] Rituximab combined with CHOP for successful treatment of aggressive recurrent, pediatric B-cell large cell non-Hodgkin's lymphoma
    Jetsrisuparb, A
    Wiangnon, S
    Komvilaisak, P
    Kularbkaew, C
    Yutanawiboonchai, W
    Mairieng, E
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (04) : 223 - 226
  • [23] Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy
    Nosotti, L.
    D'andrea, M.
    Pitidis, A.
    Pimpinelli, F.
    Dessanti, M. L.
    Pisani, F.
    Vignally, P.
    Petti, M. C.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (01) : 70 - 73
  • [24] A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma
    Arora, Mili
    Gowda, Sonia
    Tuscano, Joseph
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (04) : 209 - 221
  • [25] Superior outcomes with paediatric protocols in adolescents and young adults with aggressive B-cell non-Hodgkin lymphoma
    Gupta, Sumit
    Alexander, Sarah
    Pole, Jason D.
    Sutradhar, Rinku
    Crump, Michael
    Nagamuthu, Chenthila
    Baxter, Nancy N.
    Nathan, Paul C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 743 - 752
  • [26] Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma
    Pro, Barbara
    Leber, Brian
    Smith, Mitchell
    Fayad, Luis
    Romaguera, Jorge
    Hagemeister, Fredrick
    Rodriguez, Alma
    McLaughlin, Peter
    Samaniego, Felipe
    Zwiebel, James
    Lopez, Adriana
    Kwak, Larry
    Younes, Anas
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (03) : 355 - 360
  • [27] Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas
    Ramadan, Safaa
    Ceparano, Giusy
    Cignetti, Alessandro
    Sammassimo, Simona
    Bagnardi, Vincenzo
    Pagan, Eleonora
    Gottardi, Daniela
    Fiori, Stefano
    Passerini, Rita
    Radice, Tommaso
    Saglio, Giuseppe
    Tarella, Corrado
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13
  • [28] Emerging new cell therapies/immune therapies in B-cell non-Hodgkin's lymphoma
    Banerjee, Titas
    Vallurupalli, Anusha
    CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [29] Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma
    Dias, Catarina
    Isenberg, David A.
    NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (06) : 360 - 368
  • [30] Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma
    Liu, Yang
    Li, Yanju
    Zhang, Chike
    Yang, Xu
    Yang, Bo
    Cheng, Jinyang
    Chen, Juan
    Yuan, Xiaoshuang
    Li, Ya
    Chen, Ying
    Zhang, Fengqi
    Tang, Dongxin
    He, Zhixu
    Wang, Feiqing
    DISCOVER ONCOLOGY, 2024, 15 (01)